Macau starts using China’s Sinopharm’s Covid-19 vaccine despite a lack of Phase 3 clinical data | South China Morning Post

Despite a lack of Phase 3 clinical data from Sinopharm about its jabs, Macau has still approved the free and voluntary vaccination plan for its roughly 680,000 residents.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.